Review
Open access
Sep 2026
Immune metabolic reprogramming in MASLD.
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a major global health challenge driven by the interplay between metabolic dysregulation and chronic low-grade inflammation. Beyond simple hepatic lipid accumulation, MASLD is characterized by extensive remodeling of the liver immune microenvironment in...
Joanna Razafiarison, Nicolas Venteclef, Florent Ginhoux et al.
· JHEP Reports · 0 citations